Yizhen Pang
- Oncology top 1%
- Peptidase Inhibition and Analysis 59
- Lung Cancer Research Studies 6
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms 34
-
- Radiopharmaceutical Chemistry and Applications 16
- Surgery top 2%
- Cardiac Structural Anomalies and Repair 25
-
- Neuropeptides and Animal Physiology 10
-
- Neuroendocrine Tumor Research Advances 5
-
- Cardiac tumors and thrombi 5
- Co-authors
- Haojun ChenLong SunLiang ZhaoHua WuQin LinBing HaoZuoming LuoLong Zhao
- Journals
- Journal of Clinical Investigation (1 paper)Radiology (1 paper)Clinical Cancer Research (3 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Yizhen Pang
67 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 2.1k
- Cancer Research 1.2k
- Radiology, Nuclear Medicine and Imaging 619
- Surgery 1.1k
- Cellular and Molecular Neuroscience 419
Countries citing papers authored by Yizhen Pang
This map shows the geographic impact of Yizhen Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhen Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhen Pang more than expected).
Fields of papers citing papers by Yizhen Pang
This network shows the impact of papers produced by Yizhen Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhen Pang. The network helps show where Yizhen Pang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yizhen Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 13 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 13 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 56 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 39 | |
| 14 | 2022 | 71 | |
| 15 | 2021 | 16 | |
| 16 | 2021 | 114 | |
| 17 | 2020 | 197 | |
| 18 | 2020 | 24 | |
| 19 | 2020 | 172 | |
| 20 | 2020 | 46 |
About Yizhen Pang
Yizhen Pang is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 69 papers that have together received 2.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (59 papers), Protease and Inhibitor Mechanisms (34 papers), Cardiac Structural Anomalies and Repair (25 papers), Radiopharmaceutical Chemistry and Applications (16 papers), Neuropeptides and Animal Physiology (10 papers), Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Cardiac tumors and thrombi (5 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (1.2k citations) and Radiology, Nuclear Medicine and Imaging (619 citations). Yizhen Pang has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Haojun Chen, Long Sun, Liang Zhao, Hua Wu, Qin Lin, Bing Hao, Zuoming Luo, Long Zhao, Qihang Shang and Chengrong Xie. Their work appears in journals such as Journal of Clinical Investigation, Radiology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.